ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

YGEN Yourgene Health Plc

0.515
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Yourgene Health Plc LSE:YGEN London Ordinary Share GB00BN31ZD89 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.515 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Yourgene Health PLC COVID-19 Surge testing contract (2020J)

19/08/2021 12:04pm

UK Regulatory


Yourgene Health (LSE:YGEN)
Historical Stock Chart


From Mar 2021 to Mar 2024

Click Here for more Yourgene Health Charts.

TIDMYGEN

RNS Number : 2020J

Yourgene Health PLC

19 August 2021

Yourgene Health plc

("Yourgene" or the "Group" or the "Company")

Yourgene's COVID-19 testing investment reaps rewards

DHSC contract secured to support COVID-19 surge testing

Manchester, UK 19 August 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, confirms that Yourgene Genomic Services ('YGS') has been awarded a contract for provision of laboratory capacity to the NHS Test and Trace Programme for COVID-19 testing by the Department of Health & Social Care (DHSC).

In April 2021, the Company announced it was successful in securing tenders under Public Health England's National Microbiology Framework for Lots 1-4 and was one of only three companies to successfully be awarded all four Lots. This meant public health authorities across the UK were able to issue call-off contracts to procure goods and testing services from Yourgene.

This contract is the first to come of the National Microbiology Framework Lot wins announced earlier this year, using Yourgene's high throughput automated COVID-19 services testing laboratory in Citylabs 1.0, Manchester. The final contract notice value is the maximum estimated value of the contract. Actual value will depend on services purchased. There is no committed spend.

Lyn Rees, Chief Executive Officer, commented: "We are delighted to have been awarded this first contract from the framework, supporting the Government's testing needs utilising our recently completed high throughput COVID-19 diagnostic testing laboratory."

This announcement contains inside information for the purposes of the UK Market Abuse Regulation. The Directors of the Company take responsibility for this announcement.

 
Yourgene Health plc                                                    Tel: +44 (0)161 669 8122 
 Lyn Rees, Chief Executive Officer                                investors@yourgene-health.com 
Barry Hextall, Chief Financial Officer 
Joanne Cross, Director of Marketing 
 
Cairn Financial Advisers LLP (NOMAD)                                   Tel: +44 (0)20 7213 0880 
Liam Murray / James Caithie / Ludovico 
 Lazzaretti 
Singer Capital Markets (Joint Corporate                                Tel: +44 (0)20 7496 3000 
 Broker) 
Aubrey Powell / Tom Salvesen / George 
 Tzimas 
 
Stifel Nicolaus Europe Limited (Joint                                  Tel: +44 (0)20 7710 7600 
 Corporate Broker) 
Nicholas Moore / Matthew Blawat / Ben 
 Maddison 
 
Walbrook PR Ltd (Media and Investor         Tel: +44 (0)20 7933 8780 or yourgene@walbrookpr.com 
 Relations) 
Paul McManus / Lianne Cawthorne                         Mob: 07980 541 893 / Mob: 07584 391 303 
 
 
 

About Yourgene Health plc

Yourgene Health is an international molecular diagnostics group which develops and commercialises genomic services and technologies. The group works in partnership with global leaders in DNA technology to advance diagnostic science.

Yourgene primarily develops, manufactures, and commercialises simple and accurate molecular diagnostic solutions, for reproductive health, precision medicine and infectious diseases. The Group's flagship in vitro diagnostic products include non-invasive prenatal tests (NIPT) for Down's Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests and DPYD genotyping.

Yourgene has a range of innovative DNA sample preparation platforms, powered by Ranger(R) Technology, the Yourgene LightBench(R) and Yourgene QS250, ideal for cell-free DNA applications in NIPT and oncology including liquid biopsy.

Yourgene Genomic Services is a global laboratory service network equipped to be a full life-cycle partner for clinical, research and pharmaceutical organisations to support partners at the preclinical, clinical, and post-market stages to develop, manufacture, obtain regulatory approval and commercialise new products and services. In addition, Yourgene Genomic Services offers an NIPT and high throughput COVID testing service.

Yourgene Health is headquartered in Manchester, UK with facilities in Taipei, Singapore, the US and Canada, and is listed on the London Stock Exchange's AIM market under the ticker "YGEN". Follow us on LinkedIn and Twitter .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

CNTPLMBTMTMBBTB

(END) Dow Jones Newswires

August 19, 2021 07:04 ET (11:04 GMT)

1 Year Yourgene Health Chart

1 Year Yourgene Health Chart

1 Month Yourgene Health Chart

1 Month Yourgene Health Chart

Your Recent History

Delayed Upgrade Clock